Compounds > 25-hydroxycholesterol
Page last updated: 2024-08-24

25-hydroxycholesterol and HIV Coinfection

25-hydroxycholesterol has been researched along with HIV Coinfection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Biasin, M; Caputo, SL; Clerici, M; Fenizia, C; Ibba, SV; Mercurio, V; Saulle, I; Trabattoni, D; Vichi, F; Vittori, C1
Gomes, B; Hollmann, A; Madeddu, S; Sanna, G; Santos, NC1

Other Studies

2 other study(ies) available for 25-hydroxycholesterol and HIV Coinfection

ArticleYear
Sterol metabolism modulates susceptibility to HIV-1 Infection.
    AIDS (London, England), 2020, 09-01, Volume: 34, Issue:11

    Topics: HIV Infections; HIV Seronegativity; HIV-1; Humans; Hydroxycholesterols; Immunity, Innate; Leukocytes, Mononuclear; MicroRNAs; Real-Time Polymerase Chain Reaction; Steroid Hydroxylases; Sterols; Virus Internalization

2020
Combining 25-Hydroxycholesterol with an HIV Fusion Inhibitor Peptide: Interaction with Biomembrane Model Systems and Human Blood Cells.
    ACS infectious diseases, 2019, 04-12, Volume: 5, Issue:4

    Topics: Anti-HIV Agents; Cell Membrane; Erythrocytes; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Hydroxycholesterols; Leukocytes, Mononuclear; Peptides

2019